AGIOS PHARMACEUTICALS, INC.
Pioneering cellular metabolism therapies for rare, genetically defined diseases like anemias.
AGIO | NDAQ
Overview
Corporate Details
- ISIN(s):
- US00847X1046
- LEI:
- Country:
- United States of America
- Address:
- 88 SIDNEY STREET, 2139 CAMBRIDGE
- Website:
- https://www.agios.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Agios Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company pioneering therapies for genetically defined diseases. The company leverages its leadership and expertise in the science of cellular metabolism to discover, develop, and commercialize innovative medicines. Its primary therapeutic focus is on rare diseases, with a near-term concentration on hemolytic and acquired anemias. Agios is committed to developing disease-modifying, long-term treatments for patients with significant unmet medical needs, guided by a patient-centric and collaborative approach.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all AGIOS PHARMACEUTICALS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for AGIOS PHARMACEUTICALS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for AGIOS PHARMACEUTICALS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
